Health Trials

Assessment of Oral Caffeine Intake in Changing the Severity of Acute Migraine Attack Using VAS Score Among Patients Attending Headache and Neurology Outpatients Clinic of Ainshams University Hospitals

ConditionsMigraineMigraine DiseaseMigraine HeadacheMigraine Headache, With or Without AuraMigraine, Acute
Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age18-60
SponsorAin Shams University

About this trial

Caffeine extracted from green tea to abort acute attack of Migraine

Eligibility criteria

Qualifiers

None

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Caffeine (200 mg)
  • triptans
  • NSAID (Nonsteroidal anti-inflammatory drugs)
  • Paracetamol (acetaminophen)

Treatment groups

120 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Ain Shams University

Lead sponsor

Source ClinicalTrials.gov